PRLD · Prelude Therapeutics Inc · Exempt Offerings
Market Cap
$366.30M
Shares
79.80M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1678660
CUSIP
74065P101
13F (30d)
49 filings
49 filers
Visit website
Investor relations